Join the discussion — anonymously
Sign in to comment, reply, and vote. Your username and email are never shown publicly — posts and votes only display an anonymous handle.
Comments (2)
It is honestly exhausting to watch the corporate speak mask the reality of these layoffs. 'Strategic alignment' is just a cold way of saying they are cutting costs at the expense of livelihoods. The Lanham facility closure is a massive blow, and the lack of transparency about future plans only adds to the anxiety. When you have people putting in years of hard work only to be blindsided by a WARN notice, it really makes you question the stability of the entire company. We are all just waiting for the next shoe to drop at this point.
I have been tracking the restructuring trends across the industry, and unfortunately, Gilead isn't an outlier. While the Maryland situation is devastating for those 79 employees, this is becoming the standard playbook for biotech giants trying to satisfy investors. Don't be surprised if they start trimming the fat in Foster City soon under the guise of efficiency. It is a grim reality, but until they hit their growth targets, none of the regional hubs are truly safe from the next wave of 'optimizations.' Keep your resumes updated and stay vigilant.